Japanese Pharmaceutical Company Touts Ivermectin’s ‘Antiviral Effect’ Against COVID-19

  • by:
  • 03/02/2023

Japanese trading and pharmaceutical company Kowa Co. Ltd. said Monday that ivermectin shows an “antiviral effect” against the omicron variant and others. 

The statement was based on joint, non-clinical trials the company has been running with Tokyo’s Kitasato University, Just the News reports

It is no secret that the drug is extremely controversial. It is not approved for use in treating the virus in Japan, and in the U.S., the FDA continues to caution against its use. 

While the FDA argues there have been a number of cases in which people were hospitalized after self-medicating with the drug, there have also been several cases of it being used to successfully treat COVID-19 in unvaccinated and vaccinated patients. 

Ivermectin is currently being studied in the United Kingdom in a trial through Oxford University. 

Image: by is licensed under
ADVERTISEMENT

Opinion

View All

Polish farmers march in streets of Warsaw to protest EU Green Deal and Ukrainian imports

"We are protesting because we want the 'green deal' to be lifted, as it will lead our farms to bankru...

EXCLUSIVE: The CIA spy bases in Ukraine were part of a 'series of coups' started under Obama to upend stable governments

"When we see something, we start pulling threads, and those threads sometimes unravel a tapestry,"...

HUMAN EVENTS: Florida’s libel bill paves the road to free speech Hell

A sloppy, overbroad bill like this, which could and would be weaponized by well-heeled Leftists both ...

BRILYN HOLLYHAND: Young voters know Joe Biden is unfit to serve

Whether I’m in Manchester, Des Moines, Las Vegas, Dallas, or Milwaukee, the message I hear from my ge...